CSL Ltd (ASX: CSL) shares are marching higher today.

Shares in the S&P/ASX 200 Index (ASX: XJO) biotech giant closed on Friday trading for $172.32. In late morning trade on Monday, shares are changing hands for $173.38 apiece, up 0.6%.

For some context, the ASX 200 is up 0.3% at this same time.

Today’s outperformance is par for the course for stockholders since CSL shares closed at a multi-year low of $92.24 on 3 June.

Indeed, with today’s intraday moves factored in, the share price is up a whopping 88.0% since plumbing that low water mark less than three months ago.

Atop those capital gains, investors who hold the stock at market close next Tuesday, 8 September, will receive the final unfranked CSL dividend of $2.277 a share. CSL will pay that dividend on 2 October.

CSL stock trades on a 2.4% unfranked dividend yield (partly trailing partly pending).

Why did the ASX 200 biotech stock plunge to multi-year lows in June?

Despite the remarkable turnaround since 3 June, CSL shares remain down 39% since January 2025.

The company has faced a number of headwinds that saw investors reaching for their sell buttons.

Among these, was the management’s announcement of their intent to spin off the CSL Seqirus segment, its influenza vaccine business, into a separate ASX-listed company.

The company has also been hit by lower than forecast plasma demand, which were partly to blame for CSL’s repeated earnings downgrades.

And investors were taken off guard by former CSL CEO Paul McKenzie’s unexpected exit in February this year.

But, judging by the surging share price these last three months, CSL’s FY 2026 ‘reset’ looks to be paying off handsomely.

And looking to ahead, Morgans’ Damien Nguyen believes the ASX 200 biotech stock remains an appealing opportunity (courtesy of The Bull).

Here’s why.

Should I buy CSL shares today?

“CSL is a global healthcare leader with strong competitive advantages across plasma therapies, vaccines and specialty medicines,” Nguyen said. “Demand for its products remain largely independent of economic conditions.”

Summarising his buy recommendation on CSL shares, Nguyen concluded:

In our view, the latest full year result in 2026 is generating confidence that repeated earnings downgrades are behind CSL.

With defensive earnings, global market leadership and attractive long term growth prospects, we view CSL as an appealing investment opportunity.

What did CSL report for FY 2026?

CSL announced its FY 2026 results on 18 August.

While the company reported a 1% year-on-year decline in revenue to US$15.8 billion, that came in well ahead of its revised guidance (issued in May) of US$15.2 billion.

Management also painted a more positive outlook for FY 2027.

“FY26 has been a year of reset. We have taken decisive action and created a clear path to return to sustainable growth,” CSL interim CEO Gordon Naylor said.

CSL expects steady revenue in FY 2027, while underlying net profit after tax (NPAT) is forecast to grow by around 5%.

CSL shares closed up 17.3% on the day the results were released.

The post Up 88%! Why CSL shares remain an ‘appealing’ buy today appeared first on The Motley Fool Australia.

More reading

• Experts name 2 ASX 200 blue chip shares to buy this week
• Buy, hold, sell: Commonwealth Bank, Goodman Group, CSL shares
• CSL shares have surged 49%: Are brokers finally turning bullish?
• Should I buy CSL shares before the end of August?
• Buy, hold, sell: CSL, BHP, Westpac shares

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended CSL. The Motley Fool Australia has recommended CSL. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Endeavour Group Ltd (ASX: EDV) shares are edging higher on Monday after a difficult end to reporting season.

At the time of writing, the Endeavour share price is up 0.96% to $3.14.

That follows a rough week for shareholders, with the stock falling around 12% and briefly touching a 3-month low of $3.08.

However, a new ASX filing released after market open has given investors something else to think about.

So, has the recent sell-off gone too far?

CEO loads up

According to the latest ASX filing, chief executive Jayne Hrdlicka bought 323,468 Endeavour shares across 25, 26, and 27 August.

The purchases were made at prices between $3.06 and $3.106 per share and totalled just under $1 million.

That lifted her indirect holding from 4,196 shares to 327,664 shares.

This is a pretty sizeable purchase, especially after the shares were hit hard following last week’s FY26 result.

Endeavour shares are now down around 18% over the past 12 months and are trading well below their 52-week high of $4.12.

Why have Endeavour shares been falling?

The latest result showed why investors have been nervous.

Endeavour reported FY26 sales of $12.2 billion, up 1.3%, but underlying group earnings fell.

Underlying EBIT dropped 8.7% to $845 million, while underlying net profit after tax (NPAT) came in at $363 million, down 14.8%.

Retail was the biggest drag, with sales rising just 0.7% to $10 billion and underlying EBIT falling to $464 million.

Hotels held up better, with sales increasing 4.2% to $2.2 billion and underlying EBIT rising to $462 million.

Statutory profit was much weaker at $52 million after the group booked $372 million of pre-tax restructuring costs and asset write-downs.

The final dividend was also cut, with Endeavour declaring 12 cents per share for FY26.

The next test for Endeavour

Hrdlicka is now pushing ahead with a major restructure aimed at simplifying the business and improving returns.

That includes selling winery assets, cutting grape production, and reviewing weaker parts of the retail and hotel portfolio.

There have at least been some better signs early in FY27. In the first 7 weeks, retail sales were up 4.6%, while hotel sales increased 2.2%.

Brokers are still cautious, though. Recent price targets range from $2.50 at Macquarie to $3.10 at Bell Potter, putting most below the current share price.

The next test will be whether that early sales growth can continue through the rest of the first half.

Keep an eye out for Endeavour’s AGM, which will be held on 30 October.

The post Endeavour shares fell 12% last week. Is the CEO calling the bottom? appeared first on The Motley Fool Australia.

More reading

• 37 ASX shares going ex-dividend next week
• Buy, hold, sell: Whitehaven, Endeavour, Neuren Pharmaceuticals shares
• Endeavour Group FY26 profit tumbles despite sales growth
• 5 things to watch on the ASX 200 on Monday
• 10 ASX 200 shares downgraded by analysts this week

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Macquarie Group. The Motley Fool Australia has recommended Macquarie Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Winton Land Ltd (ASX: WTN) has been suspended from quotation on both the ASX and NZX, after recent board changes resulted in non-compliance with governance rules.

What did Winton Land report?

• Winton Land Limited shares suspended from the ASX under Listing Rule 17.2, following a request by the company.
• Suspension also enacted on the NZX upon the advice of NZ RegCo.
• Three directors, including two independent directors, resigned effective 31 August 2026.
• The board now has only one independent director, breaching NZX Listing Rule 2.13.2 for board and audit committee composition.
• Suspension to remain until governance requirements are met and the NZX lifts its suspension.

What else do investors need to know?

The core issue prompting this suspension is the sudden reduction in independent directors on the Winton board, leaving the company in breach of key NZX Listing Rules around board independence and audit committee composition. These rules are designed to ensure robust governance and investor confidence.

Winton Land Limited states that it expects to address these issues by appointing at least one new independent director and restructuring its audit committee. Once these steps are taken and Winton complies with the relevant governance requirements, the company anticipates both the ASX and NZX suspensions will be lifted.

What’s next for Winton Land?

Looking ahead, the immediate priority for Winton is to restore compliance with the NZX governance requirements. This will involve making new independent director appointments and ensuring the audit committee is properly composed.

Until the necessary changes are confirmed and approved by NZX, the Winton Land share price will remain suspended. Investors will be updated as soon as the company meets the listing requirements and trading resumes.

Winton Land share price snapshot

Over the past 12 months, Winton Land shares have declined 50%, significantly trailing the All Ordinaries Index (ASX: XAO).

View Original Announcement

The post Winton Land shares suspended following board resignations appeared first on The Motley Fool Australia.

More reading

• Why this ASX healthcare share is a retiree’s dream for FY27
• Up 88%! Why CSL shares remain an ‘appealing’ buy today
• Endeavour shares fell 12% last week. Is the CEO calling the bottom?
• Cobre secures majority control of Sierra Atacama Copper Project
• Why I think the VAS ETF is a top pick for beginners and experienced investors

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.